vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and HECLA MINING CO (HL). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($749.2M vs $448.1M, roughly 1.7× HECLA MINING CO). HECLA MINING CO runs the higher net margin — 30.0% vs 3.6%, a 26.4% gap on every dollar of revenue. On growth, HECLA MINING CO posted the faster year-over-year revenue change (79.5% vs 62.0%). Over the past eight quarters, HECLA MINING CO's revenue compounded faster (53.8% CAGR vs 45.0%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Hecla Mining is a leading U.S.-based precious and base metals mining firm. Core products include silver, gold, lead and zinc, with operating assets across North America. It supplies raw materials to global jewelry manufacturing, industrial production, and renewable energy segments, and is a top domestic primary silver producer.

CLOV vs HL — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.7× larger
CLOV
$749.2M
$448.1M
HL
Growing faster (revenue YoY)
HL
HL
+17.4% gap
HL
79.5%
62.0%
CLOV
Higher net margin
HL
HL
26.4% more per $
HL
30.0%
3.6%
CLOV
Faster 2-yr revenue CAGR
HL
HL
Annualised
HL
53.8%
45.0%
CLOV

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLOV
CLOV
HL
HL
Revenue
$749.2M
$448.1M
Net Profit
$27.3M
$134.4M
Gross Margin
55.4%
Operating Margin
3.6%
49.1%
Net Margin
3.6%
30.0%
Revenue YoY
62.0%
79.5%
Net Profit YoY
1027.2%
EPS (diluted)
$0.05
$0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
HL
HL
Q1 26
$749.2M
Q4 25
$487.7M
$448.1M
Q3 25
$496.6M
$409.5M
Q2 25
$477.6M
$304.0M
Q1 25
$462.3M
$261.3M
Q4 24
$337.0M
$249.7M
Q3 24
$331.0M
$245.1M
Q2 24
$356.3M
$245.7M
Net Profit
CLOV
CLOV
HL
HL
Q1 26
$27.3M
Q4 25
$-49.3M
$134.4M
Q3 25
$-24.4M
$100.7M
Q2 25
$-10.6M
$57.7M
Q1 25
$-1.3M
$28.9M
Q4 24
$-22.1M
$11.9M
Q3 24
$-9.2M
$1.8M
Q2 24
$7.4M
$27.9M
Gross Margin
CLOV
CLOV
HL
HL
Q1 26
Q4 25
55.4%
Q3 25
44.1%
Q2 25
39.3%
Q1 25
28.3%
Q4 24
27.4%
Q3 24
24.5%
24.2%
Q2 24
30.3%
20.9%
Operating Margin
CLOV
CLOV
HL
HL
Q1 26
3.6%
Q4 25
-10.1%
49.1%
Q3 25
-4.9%
36.3%
Q2 25
-2.2%
30.8%
Q1 25
-0.3%
20.0%
Q4 24
-6.4%
15.3%
Q3 24
-2.7%
9.2%
Q2 24
2.0%
16.5%
Net Margin
CLOV
CLOV
HL
HL
Q1 26
3.6%
Q4 25
-10.1%
30.0%
Q3 25
-4.9%
24.6%
Q2 25
-2.2%
19.0%
Q1 25
-0.3%
11.0%
Q4 24
-6.6%
4.8%
Q3 24
-2.8%
0.7%
Q2 24
2.1%
11.3%
EPS (diluted)
CLOV
CLOV
HL
HL
Q1 26
$0.05
Q4 25
$0.20
Q3 25
$0.15
Q2 25
$0.09
Q1 25
$0.05
Q4 24
$0.03
Q3 24
$0.00
Q2 24
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
HL
HL
Cash + ST InvestmentsLiquidity on hand
$177.6M
$301.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$339.4M
$2.6B
Total Assets
$697.7M
$3.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
HL
HL
Q1 26
$177.6M
Q4 25
$78.3M
$301.2M
Q3 25
$133.9M
Q2 25
$296.6M
Q1 25
$23.7M
Q4 24
$194.5M
$26.9M
Q3 24
$288.0M
$22.3M
Q2 24
$254.8M
$24.6M
Stockholders' Equity
CLOV
CLOV
HL
HL
Q1 26
$339.4M
Q4 25
$308.7M
$2.6B
Q3 25
$340.9M
$2.4B
Q2 25
$344.2M
$2.3B
Q1 25
$336.1M
$2.1B
Q4 24
$341.1M
$2.0B
Q3 24
$342.2M
$2.0B
Q2 24
$324.9M
$2.0B
Total Assets
CLOV
CLOV
HL
HL
Q1 26
$697.7M
Q4 25
$541.0M
$3.6B
Q3 25
$559.7M
$3.2B
Q2 25
$575.0M
$3.3B
Q1 25
$583.7M
$3.0B
Q4 24
$580.7M
$3.0B
Q3 24
$653.0M
$3.0B
Q2 24
$674.2M
$2.9B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
HL
HL
Operating Cash FlowLast quarter
$217.1M
Free Cash FlowOCF − Capex
$134.7M
FCF MarginFCF / Revenue
30.1%
Capex IntensityCapex / Revenue
18.4%
Cash ConversionOCF / Net Profit
1.61×
TTM Free Cash FlowTrailing 4 quarters
$310.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
HL
HL
Q1 26
Q4 25
$-66.9M
$217.1M
Q3 25
$12.1M
$148.0M
Q2 25
$5.4M
$161.8M
Q1 25
$-16.3M
$35.7M
Q4 24
$34.8M
$67.5M
Q3 24
$50.0M
$55.0M
Q2 24
$44.8M
$78.7M
Free Cash Flow
CLOV
CLOV
HL
HL
Q1 26
Q4 25
$-69.0M
$134.7M
Q3 25
$11.4M
$90.1M
Q2 25
$4.8M
$103.8M
Q1 25
$-16.5M
$-18.4M
Q4 24
$33.3M
$6.7M
Q3 24
$49.6M
$-690.0K
Q2 24
$44.4M
$28.3M
FCF Margin
CLOV
CLOV
HL
HL
Q1 26
Q4 25
-14.1%
30.1%
Q3 25
2.3%
22.0%
Q2 25
1.0%
34.1%
Q1 25
-3.6%
-7.0%
Q4 24
9.9%
2.7%
Q3 24
15.0%
-0.3%
Q2 24
12.5%
11.5%
Capex Intensity
CLOV
CLOV
HL
HL
Q1 26
Q4 25
0.4%
18.4%
Q3 25
0.1%
14.1%
Q2 25
0.1%
19.1%
Q1 25
0.0%
20.7%
Q4 24
0.5%
24.3%
Q3 24
0.1%
22.7%
Q2 24
0.1%
20.5%
Cash Conversion
CLOV
CLOV
HL
HL
Q1 26
Q4 25
1.61×
Q3 25
1.47×
Q2 25
2.80×
Q1 25
1.24×
Q4 24
5.66×
Q3 24
31.24×
Q2 24
6.04×
2.82×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

HL
HL

Silver Contracts$258.5M58%
Gold$129.2M29%
Zinc$30.3M7%
Lead$23.3M5%
Environmental Remediation Services$9.2M2%

Related Comparisons